|
|
News Breaks
|
November 19, 2009
|
| 06:56 EDT |  | DVAX |
| theflyonthewall.com: | Dynavax Tech completes first patient enrollment in Phase 1b hepatitis B trial | | Dynavax Technologies has completed enrollment for the first of three cohorts of patients receiving DV-601 hepatitis B therapy in a Phase 1b clinical trial. The safety profile of patients in the first cohort met pre-specified criteria for dose escalation and the second cohort has been opened for enrollment. Dynavax expects to report top-line data from this trial in the second half of 2010. DV-601 is the first hepatitis B therapy to combine both the surface and core HBV antigens, and Dynavax has retained all commercial rights to this product. :theflyonthewall.com |
|
|
News For DVAX From The Last 14 Days Check below for free stories on DVAX the last two weeks.
There are 3 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 13, 2012
|
| 09:05 EDT | | DVAX |
|
|
February 2, 2012
|
| 12:56 EDT |  | DVAX |
| | 10:17 EDT | | DVAX |
|
|
|
|
|
Subscribe for More Information